PRZOOM - /newswire/ -
Delhi, New Delhi, India, 2006/08/02 - From the confines of a generics market the Indian pharmaceutical industry has emerged as major player in the world. India’s contribution in the $552 billion global pharma industry is US $6 billion..
The Indian pharmaceutical industry is fast on its road to healthy growth. The Indian pharma sector was largely positioned as a generics market. But now it is transforming to emerge as major contributor in the global perspective.
The drive of the Indian pharma sector towards its greater share in the global industry is from its introduction of product patents in 2005. In the last twenty years, patents were only granted on processes decision. This being to the disadvantages of many multi-national companies, they exited from the country. However, it turned advantageous to India, which enabled it to become a leading producer of generic medicines.
RNCOS’ market research report, “Opportunities in Indian Pharma Sector” tells that the pharmaceutical sector in India currently shares US $6 billion of the total $552 billion global pharmaceutical industry. And this share is poised to grow at a rate of 12% every year, compared to the annual growth of 8% in the world market. This is pointed evidence to the promising scenario of the pharmaceutical market in India.
The growth of Indian pharma industry is also driven by the low drug production costs, which are 55 percent lower than in the western countries. Another reason of high growth rates is the system of contract manufacturing.
The research report on pharma sector deals with certain critical issues and facts, which are:
• The emerging trends in the pharmaceutical sector in India
• The key regulations and policy environment in the industry
• The future scenario of the pharmaceutical market in India
• The key players in this market in India
• The opportunities in Indian pharma sector
• The challenges faced by the industry
• Other economic factors affecting the market
RNCOS’ report is based on extensive research that provides objective analysis of India’s pharmaceutical sector performance. The report would be helpful for clients in analyzing the opportunities prevailing and critical for the growth of this market. It will also help investors who can refer to the detailed data and analysis on the changing dynamics of the pharmaceutical industry. The report is a valuable reference to all concerned with the Indian pharmaceutical industry and its marketing propensities.
RNCOS, incorporated in 2002, provides Market Research Reports for your business needs and aims to put an end to your information pursuit. Our expertise in gathering global business information for industry research, corporate training, growth consulting, and business consulting, brings reputed companies and firms to us for business enhancement solutions. We can be your one-stop-shop for Industry research information and niche market analysis.